Results 61 to 70 of about 36,038 (221)

Treatment Patterns in Pediatric Hidradenitis Suppurativa: Time to Treatment Initiation, Initial Treatment, and Time to Switching

Pediatric Dermatology, EarlyView.
ABSTRACT Background Hidradenitis suppurativa (HS) causes significant morbidity in children. Treatment patterns across sex, race, and ethnicity in pediatric HS have not been thoroughly evaluated. We aim to characterize treatment patterns in pediatric HS, including (1) time to treatment initiation, (2) first prescribed HS treatment, and (3) time to ...
Shaliz Aflatooni, Andrea Ure, Kimberly Smart, Julian A. Cortes, Gabriela Palma, Nicole Johnsen, Yvonne Nong, April W. Armstrong   +7 more
wiley   +1 more source

Moxifloxacin-warfarin interaction

, 2012
Two case reports presented here show elevated prothrombin time/international normalized ratios (PT/INR) following coadministration of warfarin and moxifloxacin.
Yan Ji, Youssef Hokayem
core   +1 more source

Ocular delivery of moxifloxacin-loaded liposomes

, 2018
Purpose: To determine the release profile of moxifloxacin encapsulated in liposomes in the aqueous humor as a controlled release system for intracameral application. Methods: Liposomes containing moxifloxacin were obtained using the lipid film hydration
Rafaela de Siqueira Ferraz Carvalho (5835827), Kaline Sandrelli Amorim Ferreira (5835818), Nelise de Paiva Lucena (5312993), Milena Sales Ferraz (5835824), Nereide Stela Santos Magalhães (5835833), Rodrigo Pessoa Cavalcanti Lira (5312996), Anivaldo Pereira Duarte Júnior (5835830), Bruna Marília Alves dos Santos (5835821)   +7 more
core   +1 more source

Moxifloxacin dosing in post-bariatric surgery patients [PDF]

, 2014
Introduction Given the ever increasing number of obese patients and obesity related bypass surgery, dosing recommendations in the post-bypass population are needed. Using a population pharmacokinetic (PK) analysis and PK-pharmacodynamic (PD) simulations,
T'jollyn, Huybrecht, Colin, Pieter, De Waele, Jan, Eleveld, Douglas J., Struys, Michel, Eleveld, Douglas J, Struys, Michel M. R. F., Struys, Michel M. R. F.; id_orcid, Van Bocxlaer, Jan, Van Bortel, Lucas, Colin, Pieter; id_orcid, Ruige, Johannes, Van Bortel, Luc M., Boussery, Koen   +13 more
core   +1 more source

Clinical guideline highlights for the hospitalist: Updates on the treatment of drug‐susceptible and drug‐resistant tuberculosis

Journal of Hospital Medicine, EarlyView.
Allison Stickles, Anna Poston‐Blahnik, Elizabeth Schlaudecker, Moises Huaman   +3 more
wiley   +1 more source

Antibiotic‐mediated immune modulation in periodontitis

Periodontology 2000, EarlyView.
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez, R. M. Arce, Camila Pinheiro Furquim, Cristiane Gonçalves, Alpdogan Kantarci, Magda Feres, Nidia C. Castro dos Santos   +6 more
wiley   +1 more source

Multiphoton tissue imaging by using moxifloxacin [PDF]

, 2017
Multiphoton microscopy has been widely used for in-vivo tissue imaging of various biological studies. However, its application to clinical studies has been limited due to either lack of clinically compatible exogenous contrast agents or weak ...
Wang, Taejun, Kim, Ki Hean, Chung, Euiheon, Kim, Myung Joon   +3 more
core   +1 more source

Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary Analysis

Tropical Medicine and Infectious Disease
(1) Background: The World Health Organisation (WHO) categorises moxifloxacin and levofloxacin as Group A drugs, which should be prioritised in the treatment of rifampicin-resistant tuberculosis.
Stella M. Fabiane, Chen-Yuan Chiang, Sarah K. Meredith, Meera Gurumurthy, Adamu Bayissa, Andrew J. Nunn, Ruth L. Goodall   +6 more
doaj   +1 more source

Explorative Analysis of Treatment Outcomes of Levofloxacin- and Moxifloxacin-Based Regimens and Outcome Predictors in Ethiopian MDR-TB Patients: A Prospective Observational Cohort Study

Infection and Drug Resistance, 2021
Temesgen Sidamo,1 Workineh Shibeshi,1 Getnet Yimer,2 Eleni Aklillu,3 Ephrem Engidawork1 1Department of Pharmacology & Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; 2Global One Health ...
Sidamo T, Shibeshi W, Yimer G, Aklillu E, Engidawork E   +4 more
doaj  

The Persister Character of Clinical Isolates of Staphylococcus aureus Contributes to Faster Evolution to Resistance and Higher Survival in THP-1 Monocytes: A Study With Moxifloxacin

Frontiers in Microbiology, 2020
Staphylococcus aureus may cause relapsing infections. We previously showed that S. aureus SH1000 surviving intracellularly to bactericidal antibiotics are persisters.
Tiep K. Nguyen, Tiep K. Nguyen, Frédéric Peyrusson, Magali Dodémont, Nhung H. Pham, Nhung H. Pham, Hoang A. Nguyen, Paul M. Tulkens, Françoise Van Bambeke   +8 more
doaj   +1 more source